Sobre 309 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Discover the full record of transactions filed by Frost Phillip Md Et al. Officer active across 7 companies, notably Opko Health, INC.. Cumulatively, 462 disclosures have been published. Split: 444 buys · 1 sell. Total volume traded: €22.2m. History available since 4 May 2021. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Frost Phillip Md Et al
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
150.000 títulos@ 1,6959 US$1.3% de su flujoCommon StockSEC:0000950170-25-046952:0
Salida canónica: 26 jun 2025 (T+90)
25 de 462 declaraciones
About Frost Phillip Md Et al
FROST PHILLIP MD ET AL is a declarant with 461 total filings. Across the 400 sampled recent filings, buys total EUR 22091497 and sells total EUR 51304, over the period from 2016-01-08 to 2026-02-25, and the most common transaction nature is Acquisition. The named company roles are CEO & Chairman at Opko Health, INC., Director at Cocrystal Pharma, Inc., Fluent, Inc., Director at LADENBURG THALMANN FINANCIAL SERVICES INC, Nocopi Technologies INC, and Director at IDI, Inc.